Rapid Micro Biosystems (RPID) Current Assets (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Current Assets of $49.2 million for Q1 2026, down 28.85% on a YoY basis from $69.2 million in Q1 2025, and down 19.52% sequentially from $61.2 million in Q4 2025.
Rapid Micro Biosystems (RPID) Current Assets (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Current Assets data on file, last reported at $49.2 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 28.85% year-over-year to $49.2 million; the trailing twelve-month figure through Mar 2026 stood at $49.2 million (down 28.85% YoY), and the FY2025 full-year result was $61.2 million, down 24.41% from the prior year.
- Current Assets retreated to $49.2 million in Q1 2026, from $61.2 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $186.9 million in Q1 2022 to a low of $49.2 million in Q1 2026.
- A 5-year average of $107.3 million and a median of $108.2 million in 2024 frame the typical range for Current Assets.
- Peak annual rise in Current Assets reached 45.27% in 2022, while the deepest fall reached 40.79% in 2022.
- Tracing RPID's Current Assets over 5 years: stood at $138.6 million in 2022, then slipped by 13.11% to $120.4 million in 2023, then tumbled by 32.8% to $80.9 million in 2024, then fell by 24.41% to $61.2 million in 2025, then decreased by 19.52% to $49.2 million in 2026.
- Business Quant data shows RPID's Current Assets at $49.2 million in Q1 2026, $61.2 million in Q4 2025, and $70.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 49.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.23 Mn |
| Dec 31, 2025 | 61.17 Mn |
| Sep 30, 2025 | 69.95 Mn |
| Jun 30, 2025 | 60.15 Mn |
| Mar 31, 2025 | 69.18 Mn |
| Dec 31, 2024 | 80.92 Mn |
| Sep 30, 2024 | 87.93 Mn |
| Jun 30, 2024 | 98.20 Mn |
| Mar 31, 2024 | 108.16 Mn |
| Dec 31, 2023 | 120.42 Mn |
| Sep 30, 2023 | 115.05 Mn |
| Jun 30, 2023 | 132.75 Mn |
| Mar 31, 2023 | 129.15 Mn |
| Dec 31, 2022 | 138.58 Mn |
| Sep 30, 2022 | 144.58 Mn |
| Jun 30, 2022 | 171.48 Mn |
| Mar 31, 2022 | 186.90 Mn |
| Dec 31, 2021 | 218.12 Mn |
| Sep 30, 2021 | 244.16 Mn |
| Jun 30, 2021 | 118.05 Mn |